Abstract
Allopurinol is widely used as a hypouricemic agent in man. This compound serves as both a substrate and an inhibitor of xanthine oxidase the enzyme which catalyses the oxidation of hypoxanthine to xanthine and xanthine to uric acid. Allopurinol itself is rapidly oxidized in vivo by xanthine oxidase to oxipurinol, which is also an inhibitor of xanthine oxidase,
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fox, R. M.; Royse-Smith, D.; O’Sullivan, W. J.: Science 168, 861 (1970)
Kelley, W. N.; Beardmore, T. D.: Science l69, 388 (1970)
Rogers, L. E.; Porter, P. St.: Pediatrics 42, 423 (1968)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Plenum Press, New York
About this chapter
Cite this chapter
Gröbner, W., Walter, I., Rauch-Janssen, A., Zöllner, N. (1977). The Influence of Allopurinol in Customary and in Slow Release Preparation on Different Parameters of Purine and Pyrimidine Metabolism. In: Müller, M.M., Kaiser, E., Seegmiller, J.E. (eds) Purine Metabolism in Man—II. Advances in Experimental Medicine and Biology, vol 76B. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3285-5_45
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3285-5_45
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3287-9
Online ISBN: 978-1-4684-3285-5
eBook Packages: Springer Book Archive